20247 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
Method of using catalpic acid to treat dyslipidemia
#2402Unsaturated Fatty Acids as Thrombin Inhibitors
#2403Compositions and methods for treatment of optic nerve diseases
#2404Compositions ameliorating a reduced diurnal activity and/or depressive symptoms
#2405Method for producing polyunsaturated fatty acids in transgenic plants
#2406METHOD FOR TREATING AND/OR PREVENTING INFECTIONS IN INFANTS DELIVERED VIA CAESAREAN SECTION
#2407Preventing diseases in infants delivered via caesarean section
#2408Osteogenic and anti-adipogenic oxysterols
#2409Method for treatment and prevention of respiratory insufficiency
#2410Lipotoxicity relieving agent
#2411USE OF RXR AGONISTS FOR THE TREATMENT OF OSTEOARTHRITIS
#2412Method of enhancing reproductive function of mammals by feeding of conjugated linoleic acids
#2413Very long chain polyunsaturated fatty acids, methods of production, and uses
#2414Use of a Polyunsaturated Fatty Acid Compound
#2415PROPHYLACTIC DOCOSAHEXAENOIC ACID THERAPY FOR PATIENTS WITH SUBCLINICAL INFLAMMATION
#2416Use of a polyphenol in the treatment of the metabolic syndrome and endothelial dysfunction or other vascular sequellae
#2417METHODS OF IMPROVING DHA DEPOSITION AND RELATED FUNCTION AND/OR DEVELOPMENT
#2418Biocompatible Latent Emulsifiers
#2419Materials and Methods for Treatment of Pathological Ocular Vascular Proliferation
#2420Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
#2421USE OF NUTRITIONAL COMPOSITIONS WITH PHOSPHOLIPID, SPHINGOLIPID AND CHOLESTEROL.
#2422Salts of Fatty Acids and Methods of Making and Using thereof
#2423Pharmaceutical Composition and Method for Treating Hypertriglyceridemia and Hypercholesterolemia in Humans
#2424Treatment of Fatty Liver
#2425Composition for slowing down the development of alzheimer's disease
#2426Method for producing a conjugated linoleic acid glyceride
#2427Non-allergenic ingredients and food products
#2428Nanoveso™: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases
#2429Use of a RAR antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects
#2430COMBINATION COMPRISING SQUALENE, A PHOSPHOLIPID AND AN OMEGA 3 FATTY ACID FOR THE TREATMENT OF CANCER
#2431Method for Stimulating the Intestinal Flora
#2432Composition for preventing the occurrence of cardiovascular event in multiple risk patient
#2433Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers
#2434Infant nutritional compositions for preventing obesity
#2435PET FOOD COMPOSITIONS AND METHODS
#2436PET FOOD COMPOSITIONS AND METHODS
#2437MATERNAL SUPPLEMENT
#2438Compositions and methods for modulating immune function
#2439Nutrition with lipids and non-digestible saccharides
#2440USE OF ADENOSINE RECEPTOR LIGANDS TO PROMOTE CELL ADHESION IN CELL-BASED THERAPIES
#2441Composition for Improving Lipid Metabolism
#2442Reduction of sterols and other compounds from oils
#2443Compositions and methods for the treatment of ophthalmic conditions
#2444CAROTENOID-CONTAINING COMPOSITIONS AND METHODS
#2445Methods for enhancing the quality of life of a senior animal
#2446Jelly composition
#2447Cancer Therapy And Medicaments Therefor
#2448PUFA SUPPLEMENTS
#2449METHOD FOR REDUCING THE SEVERITY OF NEUROLOGICAL DISORDERS
#2450Omega-3 mixtures
#2451Method for regulating gene expression
#2452Immune response modifier formulations containing oleic acid and methods
#2453Method for placental exfoliation using oxo-arachidonic acid or the like
#2454Pharmaceutical Compositions Containing Omega 3 Fatty Acids
#2455Method for reducing the severity of neurological disorders
#2456Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals
#2457Glycerophospholipids for the improvement of cognitive functions
#2458Active composition for treatment or prevention of problems related to a disturbance of the biological clock
#2459TGF-alpha expression inhibitors
#2460ANTI-PROLIFERATIVE COMBINATIONS
#2461METHOD FOR MAKING KRILL MEAL
#2462Delivery and controlled release of encapsulated lipophilic nutrients
#2463Use of a Fatty Acid Composition Containing DHA for the Production of a Medical Product or a Food Stuff for the Treatment of Amyloidos-Related Diseases
#2464COMPOSITION WITH DOCOSAPENTAENOIC ACID
#2465Compositions for Ameliorating a Reduced Higher Brain Function Resulting From Organic Brain Lesions
#2466Novel Statin Pharmaceutical Compositions and Related Methods of Treatment
#2467Polyphenol coxib combinations and methods
#2468COMPOSITIONS FOR INHIBITING AND PREVENTING VASCULAR OCCLUSION CONTAINING NUTRITIONAL SUPPLEMENTS
#2469Composition for improving membrane composition and functioning of cells
#2470STABLE BEVERAGE PRODUCTS COMPRISING POLYUNSATURATED FATTY ACID EMULSIONS
#2471Pharmaceutical Composition and Its Use
#2472Rxr Antagonist Treatment Against Multiple Sclerosis
#2473Omega-3 Fatty Acids and Dyslipidemic Agent for Lipid Therapy
#2474Oligomers of straight-chain and unbranched fatty acids and drugs containing these
#2475Spot-on formulation useful for cosmetology and dermatology
#2476Composition for improving membrane composition and functioning cells
#2477Therapeutic intervention to MIMIC the effect of caloric restriction
#2478Method of using catalpic acid to treat hyperinsulinemia
#2479METHOD FOR TREATING RENAL DISEASE
#2480Treatment and prevention of major adverse cardiovascular events or major coronary evens by administering Omega-3 fatty acids
#2481Taxane derivative containing pharmaceutical composition with improved therapeutic efficacy
#2482COMPOSITION FOR IMPROVING MEMBRANE COMPOSITION AND FUNCTIONING CELLS
#2483Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage
#2484Composition for improving membrane composition and functioning of cells
#2485Food Supplement Based on Group B Vitamins, Trace Elements and -3 and/or 6- Fatty Acids and Use of This Food Supplement in the Simultaneous Treatment of Localized Cellulite and Slackening of the Skin
#2486Treatment and prevention of bone loss using resolvins
#2487Treatment and prevention of liver disease associated with parenteral nutrition (PN)
#2488Bioeffective krill oil compositions
#2489Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events
#2490Nutrition containing fat blend
#2491OMEGA 3 FATTY ACID FORMULATIONS
#2492Anti-microbial agent
#2493Composition Containing Omega-3 Fatty Acids and Omega-6 Fatty Acids
#2494FORMULATIONS OF LIPOPHILIC BIOACTIVE MOLECULES
#2495Methods for Reducing the Effects of Stress on Skin Condition
#2496Nutritional formulation for promoting catch-up growth
#2497Rxr Antagonists in the Treatment of Inflammatory Diseases
#2498COMPOSITION AND METHOD FOR WEIGHT LOSS
#2499Method and composition for increasing Erythropoietin
#2500POLYUNSATURATED FATTY ACIDS FOR TREATMENT OF DEMENTIA AND PRE-DEMENTIA-RELATED CONDITIONS
#2501Treatment for Asthma and Arthritis and Other Inflammatory Diseases
#2502Products containing highly unsaturated fatty acids for use by women during stages of preconception, pregnancy and lactation/post-partum
#2503Method for growing photosynthetic organisms
#2504Approach to anti-microbial host defense with molecular shields with lipoxin compounds
#2505Methods of treating hyperlipidemia
#2506Gastric Therapies Amd Compositions Therefor
#2507Fatty acid formulations and methods of use thereof
#2508Natural Remedy-Dietary Supplement Combination Product
#2509VITAMIN C PREPARATION
#2510Method for reducing or preventing systemic inflammation
#2511Method for the utilization of and product containing inactivated probiotic
#2512Lipotoxicity Relieving Agent
#2513Highly purified ethyl EPA and other EPA derivatives
#2514Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
#2515Preparation for the prevention and/or treatment of vascular disorders
#2516AGENTS WHICH REGULATE, INHIBIT, OR MODULATE THE ACTIVITY AND/OR EXPRESSION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AS A UNIQUE MEANS TO BOTH LOWER INTRAOCULAR PRESSURE AND TREAT GLAUCOMATOUS RETINOPATHIES/OPTIC NEUROPATHIES
#2517Elongase genes and uses thereof
#2518Pharmaceutical semi-solid composition of isotretinoin
#2519Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases
#2520Process for the Heterotrophic Production of Microbial Products with High Concentrations of Omega-3 Highly Unsaturated Fatty Acids
#2521Compositions and methods for the treatment of inflammatory disease
#2522Compounds and methods for inhibition of bone loss
#2523Method of treating muscular dystrophies with an inhibitor of histone deacetylase
#2524COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS AND CONDITIONS
#2525ISOFLAVONE-CONTAINING COMPOSITIONS FOR THE TREATMENT OF OSTEOPOROSIS AND INFLAMMATORY JOINT DISEASE
#2526Method for reducing the severity of neurological disorders
#2527Methods and kits for co-administration of nutritional supplements
#2528Method for treating diseases caused by accumulation of body fat
#2529Treatment and prevention of cardiovascular disease in patients with chronic kidney disease by administering Omega-3 Fatty Acids
#2530Nutritional composition comprising indigestible oligosaccharides
#2531Activators of peroxisome proliferator-activated receptors
#2532Treatment and prevention of intestinal fibrosis
#2533Synergistic Effects Of Docosahexaenoic Acid (DHA) And Carotenoid Absorption Of Cognitive Function
#2534Use of Omega-3 Fatty Acid(s) for Treating Hypercholesterolemia Caused by Anti-Retroviral Treatment of Hiv-Infected Patients
#2535Composition comprising dihomo-γ-linolenic acid (DGLA) as active ingredient
#2536Methods of attenuating autoimmune disease and compositions useful therefor
#2537PARTICULATE COMPOSITION COMPRISING BIOACTIVE SUBSTANCE AND METHOD OF PRODUCING THE SAME
#2538Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
#2539Composition containing statins and omega-3 fatty acids
#2540STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCTION OF APO-B LEVELS
#2541Meal replacement compositions and weight control method
#2542Methods of improving bone health and muscle health
#2543Antimicrobial agents derived from cream
#2544Lipoxin Analogs as Novel Inhibitors of Angiogenesis
#2545Lipoxins and Aspirin-Triggered Lipoxins and Their Stable Analogs in the Treatment of Asthma and Inflammatory Airway Diseases
#2546Intestinal barrier integrity
#2547Infant Formulas for Early Brain Development
#2548STABLE POLYUNSATURATED FATTY ACID EMULSIONS AND METHODS FOR INHIBITING, SUPPRESSING, OR REDUCING DEGRADATION OF POLYUNSATURATED FATTY ACIDS IN AN EMULSION
#2549Use of at Least One Conjugated Triene-Containing Fatty Acid for Preparing a Medicine for Treating Inflammation
#2550Cytotropic heterogeneous molecular lipids (CHML), method of preparation, and methods of treating patients with multiple cancers
#2551Compositions, products and methods for controlling weight in a mammal
#2552NON-ALLERGENIC INGREDIENTS AND FOOD PRODUCTS
#2553Medicine Capable of Inhibiting Activation of Transcription Factor Klf5
#2554Barrier Integrity in Hiv Patients
#2555Infant formulas for early brain development
#2556Food fortified with omega-3 fatty acids
#2557Tamanu oil products
#2558Nutritional composition comprising immunoglobulins and oligosaccharides
#2559Composition with Preventive or Improvement Effect on Stress-Induced Brain Function Impairment and Related Symptoms or Diseases
#2560Combinations of Hyaluronic Acid and Polyunsaturated Fatty Acids
#2561Type A gelatin capsule containing PUFA in free acid form
#2562COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS AND CONDITIONS
#2563Treatment of fatty liver
#2564ENHANCED PROTECTION AGAINST SKIN INJURY IN HUMANS
#2565Jelly composition
#2566Method of treating a condition associated with phosphorylation of TASK-1
#2567Composition with preventive or improvement effect on symptoms or diseases associated with stress-induced behavior disorders
#2568Compositions and methods for the treatment of cardiovascular disease
#2569Compositions for Topical Treatment
#2570Method of preventing or reducing the risk or incidence of cancer
#2571Nitrated lipids and methods of making and using thereof
#2572Use of Fatty Acids to Inhibit the Growth of Aneurysms
#2573Nutritional Compositions and Methods
#2574Pharmaceutical Compositions Containing Pufa And At Least One Of An Immunosuppressive Agent Or An Antineoplastic Agent
#2575Topical Treatment with NGF and DHA in Damaged Corneas
#2576Hormone replacement formulation
#2577Conjugated fatty acid based emulsion and methods for preparing and using same
#2578Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
#2579Materials and methods for treating and preventing Her-2/neu overexpressing, FAS-elevated cancer cells
#2580Means for improving cardiovascular health
#2581Method for preventing or reducing elevated triglyceride levels
#2582Method for preventing or treating obesity
#2583Method for preventing or treating anemia
#2584Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer
#2585Preparation for the prevention and/or treatment of vascular disorders
#2586Liquid Concentrated Formula
#2587Method for increasing the expression of pulmonary surfactant protein-B
#2588USE OF PPAR AGONISTS AS ANTI-OXIDANTS
#2589Compositions and methods for improving skin health and pelage quality
#2590Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof
#2591Conjugated fatty acid esters
#2592Method for the Prevention and Treatment of Cachexia and Anorexia
#2593Method of enhancing reproductive function of mammals by feeding of conjugated linoleic acids
#2594STATIN AND OMEGA-3 FATTY ACIDS FOR LIPID THERAPY
#2595Compositions and methods for treating feline inflammatory bowel disease
#2596PUFA supplements
#2597Use of phenserine and analogs to treat behavioral problems and improve trainability
#2598Immune response modifier formulations and methods
#2599Formulation and Methods for Use of Morinda Citrifolia Seed Oil
#2600Cholestrol-reducing agent containing an n-3 fatty acid
#2601Nutritional supplement containing long-chain polyunsaturated fatty acids
#2602Use of highly concentrated compositions of selected n-3 fatty acids for the treatment of central nervous system disturbances
#2603Peri-operative and peri-procedure nutritional supplementation
#2604Metabolic uncoupling therapy
#2605Compositions and methods for hair growth
#2606USE OF AN OMEGA-3 LIPID-BASED EMULSION FOLLOWING ISCHEMIC INJURY TO PROVIDE PROTECTION AND RECOVERY IN HUMAN ORGANS
#2607Omega 3 fatty acid formulations
#2608METHOD TO REDUCE OXIDATIVE DAMAGE AND IMPROVE MITOCHONDRIAL EFFICIENCY
#2609Composition and use of RAR antagonists for promoting chondrogenesis
#2610Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements
#2611Immune response modifier formulations containing oleic acid and methods
#2612Fat composition
#2613Use of a fatty acid composition comprising at least one of EPA and DHA or any combinations thereof
#2614Formulation containing a carboxylic acid or an ester thereof
#2615Intermediates for the preparation of lipoxin Aanalogs
#2616Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
#2617Treatment with omega-3 fatty acids and products thereof
#2618Nutritional formula for optimal gut barrier function
#2619Pharmaceutical compositions of acitretin
#2620Microorganisms that extracellularly secrete lipid particles encapsulating lipids
#2621Krill extracts for treatment of cardiovascular diseases
#2622Composition for preventing and treating varicose veins of lower extremities
#2623Methods and compositions for oral administration of proteins
#2624Agent for preventing and treating language disorders
#2625Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
#2626Method of treating a condition associated with phosphorylation of task-1
#2627Therapeutic composition for the treatment of dry eye syndrome
#2628Risk assessment and correction of membrane damage of the upper GI tract
#2629Microorganisms that extracellularly secrete lipids and methods of producing lipid and lipid vesicles encapsulating lipids using said microorganisms
#2630Microorganisms that extracellularly secrete lipids and methods of producing lipid and lipid vesicles encapsulating lipids using said microorganisms
#2631Compositions and methods for improving functional vascular cellular survival integrity and reducing apoptosis in ischemia
#2632Methods and compositions for improving visual acuity
#2633Compositions and methods for improving cellular survival and reducing apoptosis after ischemic episode in the brain
#2634Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
#2635Antiepileptogenic complex of albumin with docosahexaenoate
#2636Blockade of mtor to prevent a hormonal adaptive response
#2637Histone deacetylase inhibitors
#2638Intermediates for the preparation of lipoxin Aanalogs
#2639Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof
#2640PRODUCTS FOR TOPICAL APPLICATION COMPRISING LYSOPHOSPHOLIPIDS AND FATTY ACIDS
#2641Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions
#2642Formulations comprising fenofibrate and a statin, and related methods of treatment
#2643Infant or follow-on formula
#2644Method of increasing lean body mass and reducing body fat mass in infants
#2645Composition and/or method for preventing onset and/or recurrence of cardiovascular events
#2646Method for treating or preventing systemic inflammation in formula-fed infants
#2647Aerosol compositions and methods
#2648Method for treating renal disease
#2649Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
#2650Methods and compositions for treating Parkinson's disease
#2651Methods and compositions for treating degenerative bone disorders
#2652Use of resolvins to treat gastrointestinal diseases
#2653Method for modulating process mediated by farnesoid activated receptors
#2654Nutritional supplement and soft gelatin capsule delivery system
#2655External composition containing Unsaturated fatty acid or its salt or ester
#2656Nutraceutical compositions and use thereof
#2657Composition containing as the active ingredient componantes from salvia sclarea seed
#2658Conjugated linolenic acids and methods of preparation and purification and uses thereof
#2659Neuroprotective complex for treatment of cerebral ischemia and injury
#2660Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation
#2661Agents and methods for enhancing bone formation
#2662Fortified cereal bran to promote digestive health
#2663Conjugated fatty acid esters
#2664Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders
#2665Method for lowering serum homocysteine
#2666Nutritional products for ameliorating symptoms of rheumatoid arthritis
#2667Anti-inflammatory compositions and uses thereof
#2668Method for treating or preventing systemic inflammation in formula-fed infants
#2669Method for preventing or treating respiratory infections in infants
#2670Nutritional supplements for cardiovascular health
#2671Control of biofilm with a biofilm inhibitor
#2672Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses
#2673Nutritional preparations
#2674Nutritional preparations
#2675Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating cancer
#2676Compounds and Methods for Treating Seizure Disorders
#2677Treatment with Statin and Omega-3 Fatty Acids and a Combination Product Thereof
#2678Omega-3 fatty acids and dyslipidemic agent for lipid therapy
#2679Treatment with omega-3 fatty acids and PPAR agonist and/or antagonist and a combination product thereof
#2680Methods and compositions for cancer treatment
#2681Stabilized steroid composition and method for its preparation
#2682Trans carotenoids, their synthesis, formulation and uses
#2683Methods for the treatment of infectious and inflammatory airway diseases
#2684Use of docosahexanoic acid as active substance for the treatment of lipodystrophy
#2685Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors
#2686Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
#2687Surgical method
#2688Method of neutralising organoboronates with acids
#2689Oxidised lipids as reversal agents for boronic acid drugs
#2690Use of pinolenic acid
#2691Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
#2692Method of using catalpic acid to treat type 2 diabetes and associated disorders
#2693Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
#2694Compositions comprising fatty acids and amino acids
#2695IMPROVED COX-2 INHIBITORY COMPOSITIONS AND THERAPEUTIC REGIMEN
#2696Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating depression
#2697Use of physiologically active fatty acids
#2698Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use
#2699Compositions, products and methods for controlling weight in a mammal
#2700Use of a histone deacetylase inhibitor for treating muscular dystrophies